Infectious Disease Doctors in Rockford, IL Accepting Medicare

4 Infectious Disease doctors found. Showing 1 - 4

Geoffrey Tsaras, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1340 Charles St Ste 404, Rockford, IL 61104 Phone: 779-696-1890    Fax: 779-696-2410

Dr. Suma Rao, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 W State St, Rockford, IL 61102 Phone: 815-490-1600

Moamen Mohammad Al Zoubi, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-5000    Fax: 815-971-9537

Kavitha Subramanian, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 698 Featherstone Rd, Rockford, IL 61107 Phone: 815-398-3277    Fax: 815-484-7001

News Archive

Pfizer enters definitive merger agreement with Icagen

Pfizer Inc. and Icagen, Inc. today announced that they have entered into a definitive merger agreement. Pfizer, which currently owns approximately 11% of Icagen's fully diluted shares, will acquire the remaining 8.3 million shares at a price of $6.00 per share.

Scientists discover two body clock genes that may help find treatments for seasonal affective disorder

Scientists have discovered two "body clock" genes that reveal how seasonal changes in hormones are controlled and could ultimately help find treatments for seasonal affective disorder.

Global Health Service Corps essential to improve African health systems, achieve 'AIDS-free generation'

"A notable feature of Secretary of State Hillary Rodham Clinton's 'AIDS-free generation' initiative is to strengthen health care systems in sub-Saharan Africa, ... a view echoed by many eminent voices in the global health community," Anand Reddi of the University of Colorado Medical School writes in a post on Huffington Post's "Impact" blog.

Positive results from Supernus Pharmaceuticals' SPN 810 Phase IIa trial for ADHD

Supernus Pharmaceuticals Inc., today announced that its Phase IIa U.S. clinical trial for SPN 810 in children with ADHD and persistent serious conduct problems met the primary endpoints of safety and tolerability, as well as showed statistically significant reduction versus baseline in conduct problems across all doses. The trial was initiated in 2009 and was a proof-of-concept, open-label study in children 6 to 12 years of age, assigned to one of four doses over a six-week treatment period, after 2-5 weeks' titration.

Germ-killing robots use UV radiation to safeguard patients from health care-associated infections

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center patients from health care-associated infections.

Read more Medical News

› Verified 1 days ago